We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Events

ATTENTION: Due to the CORONAVIRUS EPIDEMIC, certain events are being rescheduled for a later date or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 May 2020 - 09 May 2020

Illustration

Mount Sinai Developing `End-to-End` Diagnostics Solution for COVID-19

Researchers and clinicians in microbiology, virology, pathology, molecular science, and immunology at the Icahn School of Medicine at Mount Sinai {(ISMMS) New York, NY, USA) and The Mount Sinai Hospital {(MSH) New York, NY, USA) are working on designing, validating, and implementing an “end-to-end” clinical pathology laboratory solution that will allow for the COVID-19 testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course. More...
04 Apr 2020
Image: Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument (Photo courtesy of Applied Biosystems)

Vela Diagnostics to Offer Manual ViroKey SARS-CoV-2 RT-PCR Test

Vela Diagnostics (Singapore) plans to offer its manual ViroKey SARS-CoV-2 RT-PCR Test after its validation is completed and is currently working with the US Food and Drug Administration (FDA) for securing Emergency Use Authorization (EUA) for the test. More...
04 Apr 2020
Illustration

Cellink Relaunches Real-Time qPCR Instrument for COVID-19

CELLINK (Boston, MA, USA) has begun reselling its qPCR instrument which can be used for the quantification and genotyping of human viral pathogens, such as SARS-CoV-2. More...
04 Apr 2020
Image: Novacyt’s real-time polymerase chain reaction (PCR) COVID-2019 IVD-CE test (Photo courtesy of Novacyt S.A.)

Novacyt's Two-Hour Coronavirus Test Gains FDA Emergency Use Approval

Novacyt S.A. (Paris, France), a specialist in clinical diagnostics, has secured Emergency Use Authorization from the FDA for its fast and easily transportable COVID-19 test which was developed by Primerdesign, its molecular diagnostics division. More...
04 Apr 2020
Image: VITROS Anti-SARS-CoV-2 Total Reagent Pack (Photo courtesy of Ortho Clinical Diagnostics)

Ortho Clinical Diagnostics Releases COVID-19 Antibody Test

Ortho Clinical Diagnostics (Raritan, NJ, USA) has launched its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack. More...
04 Apr 2020
Image: The Chembio DPP platform (Photo courtesy of Chembio Diagnostics, Inc.)

Chembio Launches DPP COVID-19 Serological Point-of-Care Test

Chembio Diagnostic Systems, Inc. (Medford, NY, USA), a point-of-care diagnostic company focused on infectious diseases, has launched its rapid DPP COVID-19 serological point-of-care test for the detection of IgM and IgG antibodies in the US. More...
03 Apr 2020
Illustration

Amgen Partners with Adaptive Biotechnologies to Develop COVID-19 Treatments

Amgen (Thousand Oaks, CA, USA) is collaborating with Adaptive Biotechnologies (Seattle, WA, USA) to help address the COVID-19 pandemic. More...
03 Apr 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.